Cadre’s second quarter saw a negative market reaction, with shares dropping sharply as investors digested both a revenue beat and a reduction in full-year guidance. Management cited resilient demand for its protection products and the addition of Carr’s Engineering to its nuclear safety business as key drivers for the quarter. However, the company acknowledged increased uncertainty in its operating environment, especially around the timing of large orders, which contributed to the cautious investor response. CEO Warren Kanders noted, “We continue to see strong and recurring demand for our suite of protection products...despite a fluid macro environment.”

Is now the time to buy CDRE? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Cadre’s Q2 Earnings Call

• Lawrence Scott Solow (CJS Securities) asked about the nature and timing of delayed contracts. President Brad Williams explained that large opportunities across all major business lines were delayed, but not lost, and that funding remains intact.
• Jeffrey Van Sinderen (B. Riley Securities) questioned whether the guidance reduction was purely timing or indicated lost business. Williams confirmed the change was entirely due to order timing and not related to shrinking demand.
• Sheila Kahyaoglu (Jefferies) inquired about pricing power across Cadre’s product portfolio. Williams noted pricing hit targets in Q2 and expects recent price increases to support margins through the second half.
• Mark Smith (Lake Street) probed Cadre’s exposure to border patrol and ICE spending. Williams described ongoing expansion in these agencies, which is expected to create further product demand as headcounts rise.
• Matthew Koranda (ROTH Capital) sought clarity on commercial synergies from the Carr’s Engineering acquisition. Williams said it is early, but the nuclear businesses are collaborating to identify cross-selling and operational opportunities.

Catalysts in Upcoming Quarters

Over the coming quarters, the StockStory team will be closely monitoring (1) the pace at which delayed large contracts in public safety and nuclear are awarded and recognized, (2) the success of cost management efforts to offset tariff and integration-related margin pressure, and (3) the realization of commercial and operational synergies from the Carr’s Engineering acquisition. Progress in these areas will be key to supporting a rebound in growth and profitability.

Cadre currently trades at $28.44, down from $34.62 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

The Best Stocks for High-Quality Investors

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.